| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly has demonstrated significant progress in product development, particularly in the area of diabetes and obesity treatment with its oral weight-loss pill, orforglipron. Successful clinical trial results have positioned the company as a leader in innovative therapies, enhancing patient accessibility through convenient administration methods. The emphasis on domestic production further supports local innovation and reflects the company's commitment to quality. These advancements are likely to strengthen market competitiveness and improve patient outcomes. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.2 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.4, and the negative at -0.2 on 2025-04-23. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-23 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| 2025-04-22 | 0%(0%) | 0 | 0% | 0.3 | 2.7 | -1 | |||||||
| 2025-04-21 | 0%(0%) | 0 | 0% | 0.2 | 2 | -1 | |||||||
| 2025-04-20 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| 2025-04-19 | 0%(0%) | 0 | 0% | 0.1 | 1.3 | -1 | |||||||
| 2025-04-18 | 0%(0%) | 0 | 0% | 0 | 1 | -1 | |||||||
| 2025-04-17 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-04-16 | 0%(0%) | 0 | 0% | -0.1 | 0.2 | -1 | |||||||
| 2025-04-15 | 0%(0%) | 0 | 0% | -0.4 | -1.3 | -1 | |||||||
| 2025-04-14 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:07:00 The legal actions taken by Eli Lilly indicate the significant influence of regulatory challenges on the sales and marketing of pharmaceutical products. |
| 2025-05-19 17:07:00 The healthcare sector, particularly companies like Eli Lilly, tends to remain resilient during economic downturns, highlighting a broader industry trend. |
| 2025-05-19 17:07:00 Analysts are expressing mixed but optimistic views on Eli Lilly's stock, recognizing its potential despite some price target reductions. |
| 2025-05-19 17:07:00 Eli Lilly is facing legal challenges against telehealth companies that are selling unapproved versions of its weight-loss drugs, impacting its market position. |
| 2025-05-19 17:07:00 Eli Lilly's robust performance and sales growth in the weight loss market, primarily due to its GLP-1 agonists, indicates a significant and lucrative industry trend. |